Skip to main content
VulnerabilityPublished

CVE-2026-3401: SourceCodester Web-based Pharmacy Product Management System · Session Expiration

Affects SourceCodester Web-based Pharmacy Product Management SystemSource CVE Database V5

0
Compare

Public exploit available · CVSS 2.3 Low.

Data as of 30 Oct 2026, 11:52 UTC

CVSS 4.0 base score
2.3Low
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 30% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Mar 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: evidence found.

    CVSS exploit maturity: proof of concept public

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), CVSS vector, the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
SourceCodesterWeb-based Pharmacy Product Management SystemAffected
  • =1.0
Fixed in–

AI-suggested

To mitigate CVE-2026-3401, organizations should implement the following specific measures: 1) Monitor for official patches or updates from SourceCodester and apply them promptly once available. 2) Review and strengthen session management configurations, including session timeout values, secure cookie attributes (HttpOnly, Secure), and session token regeneration policies. 3) Implement network-level controls such as web application firewalls (WAFs) to detect and block suspicious session manipulation attempts. 4) Enforce strict access controls and privilege management to limit the ability of low-privilege users to exploit the vulnerability. 5) Conduct regular security assessments and penetration testing focused on session management to identify and remediate weaknesses proactively. 6) Educate system administrators and users about the importance of secure session handling and recognizing potential session-related anomalies. These targeted actions go beyond generic advice by focusing on session-specific controls and proactive monitoring tailored to the affected product's context.

Description

A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.

References

Community reviews

Loading reviews…